Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

A blood biomarker for monitoring response to anti-EGFR therapy.

Hughes NP, Xu L, Nielsen CH, Chang E, Hori SS, Natarajan A, Lee S, Kjær A, Kani K, Wang SX, Mallick P, Gambhir SS.

Cancer Biomark. 2018;22(2):333-344. doi: 10.3233/CBM-171149.

PMID:
29689709
2.

A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.

Hori SS, Lutz AM, Paulmurugan R, Gambhir SS.

Cancer Res. 2017 May 15;77(10):2570-2584. doi: 10.1158/0008-5472.CAN-16-2904. Epub 2017 Mar 10.

3.

Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker.

Ronald JA, Chuang HY, Dragulescu-Andrasi A, Hori SS, Gambhir SS.

Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3068-73. doi: 10.1073/pnas.1414156112. Epub 2015 Feb 23.

4.

Detection and quantitation of circulating tumor cell dynamics by bioluminescence imaging in an orthotopic mammary carcinoma model.

Sasportas LS, Hori SS, Pratx G, Gambhir SS.

PLoS One. 2014 Sep 4;9(9):e105079. doi: 10.1371/journal.pone.0105079. eCollection 2014.

5.

Mathematical model identifies blood biomarker-based early cancer detection strategies and limitations.

Hori SS, Gambhir SS.

Sci Transl Med. 2011 Nov 16;3(109):109ra116. doi: 10.1126/scitranslmed.3003110.

6.

Role of endosomal trafficking dynamics on the regulation of hepatic insulin receptor activity: models for Fao cells.

Hori SS, Kurland IJ, DiStefano JJ 3rd.

Ann Biomed Eng. 2006 May;34(5):879-92. Epub 2006 Apr 29.

PMID:
16708271

Supplemental Content

Support Center